Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytotoxic, CD8+ T-lymphocytes. Here we show that these cytotoxic T-lymphocytes perturb retrograde axonal transport. Using fluorogold stereotactically injected into the colliculus superior, we found that PLP overexpression in oligodendrocytes led to significantly reduced retrograde axonal transport in retina ganglion cell axons. We also observed an accumulation of mitochondria in the juxtaparanodal axonal swellings, indicative for a disturbed axonal transport. PLP overexpression in the absence of T-lymphocytes rescued retrograde axonal transport defects and abolished axonal swellings. Bone marrow transfer from wildtype mice, but not from perforin- o...
Background: Autoimmunity to neuronal proteins occurs in several neurological syndromes, where cellul...
We have examined the influence that axons may have on the expression of proteolipid protein (PLP), t...
Axonal degeneration contributes to clinical disability in the acquired demyelinating disease multipl...
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytoto...
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytoto...
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytoto...
Overexpression of the major myelin protein of the CNS, proteolipid protein (PLP), leads to late-onse...
Acknowledgements: We thank H. Blazyca and B. Meyer for technical assistance and J. Schreiber, A. Wei...
Oligodendrocytes are critical for the development of the plasma membrane and cytoskeleton of the axo...
Myelin mutations in the central and peripheral nervous system lead to severely disabling, currently ...
It is widely thought that demyelination contributes to the degeneration of axons and, in combination...
Glial cells produce myelin and contribute to axonal morphology in the nervous system. Two myelin mem...
Protein tyrosine phosphatase receptor type Z (Ptprz) is widely expressed in the mammalian central ne...
Although proteolipid protein (PLP) and its DM20 isoform are the major membrane proteins of CNS myeli...
We used the <i>Plp1</i>-overexpressing transgenic mouse model to investigate whether pro...
Background: Autoimmunity to neuronal proteins occurs in several neurological syndromes, where cellul...
We have examined the influence that axons may have on the expression of proteolipid protein (PLP), t...
Axonal degeneration contributes to clinical disability in the acquired demyelinating disease multipl...
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytoto...
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytoto...
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytoto...
Overexpression of the major myelin protein of the CNS, proteolipid protein (PLP), leads to late-onse...
Acknowledgements: We thank H. Blazyca and B. Meyer for technical assistance and J. Schreiber, A. Wei...
Oligodendrocytes are critical for the development of the plasma membrane and cytoskeleton of the axo...
Myelin mutations in the central and peripheral nervous system lead to severely disabling, currently ...
It is widely thought that demyelination contributes to the degeneration of axons and, in combination...
Glial cells produce myelin and contribute to axonal morphology in the nervous system. Two myelin mem...
Protein tyrosine phosphatase receptor type Z (Ptprz) is widely expressed in the mammalian central ne...
Although proteolipid protein (PLP) and its DM20 isoform are the major membrane proteins of CNS myeli...
We used the <i>Plp1</i>-overexpressing transgenic mouse model to investigate whether pro...
Background: Autoimmunity to neuronal proteins occurs in several neurological syndromes, where cellul...
We have examined the influence that axons may have on the expression of proteolipid protein (PLP), t...
Axonal degeneration contributes to clinical disability in the acquired demyelinating disease multipl...